SCHEMBL23710595

SCHEMBL23710595

O=C(OCC(OC(CO)CO)n1ccc(=O)[nH]c1=O)c1ccccc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.85
▸ HSD17B10 Q99714 1/20 0.85
▸ ALDH1A1 P00352 1/20 0.42
▸ PRKCA P17252 1/20 0.39
▸ DUT P33316 4/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ TK1 P04183 1/20 0.36
▸ ADRB2 P07550 2/20 0.36
▸ ADRB1 P08588 2/20 0.36
▸ ADRB3 P13945 2/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ SLC6A2 P23975 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ DDB1 Q16531 1/20 0.34
▸ CRBN Q96SW2 1/20 0.34
▸ SLC1A5 Q15758 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13443477 0.94 POLB (0.79) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL25611288 0.91 POLB (0.84) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL20052005 0.89 POLB (0.72) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL14867637 0.86 POLB (0.68) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL24772316 0.86 POLB (0.68) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL23710643 0.86 POLB (0.68) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL23710592 0.86 POLB (0.67) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL25583967 0.85 POLB (0.69) POLBHSD17B10ALDH1A1PRKCADUT
SCHEMBL36571379 0.83 POLB (0.66) POLBHSD17B10PRKCADUTTK1
SCHEMBL25611387 0.81 POLB (0.63) POLBHSD17B10ALDH1A1DUTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238595-A1 MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT ALNYLAM PHARMACEUTICALS, INC. (US) 2021-08-05 — — US disclosed
Send feedback